Morel Yannis

[Innate Pharma @InnatePharma]

#AACR19 “#InnateImmunity & complement in #SolidTumors” Chair @EricVivier1 @InnatePharma's CSO @aphm_actu @univamu @Immunopole

[Horowitz Lab @Icahn School of Medicine Mount Sinai @AmirHorowitz]

Brilliant talk by @EricVivier1 @InnatePharma describing Innate's portfolio of biologics aimed at modulating of NK cell and CD8 T cell functions in TME. Very exciting to see unpublished data on bi-specific engagers as well as on adenosine pathway.

[Innate Pharma @InnatePharma]

Our friend, #AlessandroMoretta (1953–2018): cofounder of @InnatePharma, Professor at @UniGenova, major figure of #CancerImmunology, one of the founding fathers of #NKimmunotherapy with @EricVivier1 See @NatImmunol https://t.co/hyn2kNrM4z @ImmunityCP https://t.co/cA5GytjLgT

[Innate Pharma @InnatePharma]

#AACR19 @EricVivier1 @InnatePharma: the #CD39-blocking antibody (IPH5201) promotes #antitumorimmunity across a wide range of tumors by preventing the production of #adenosine & promoting the accumulation of ATP in the #TumorMicroEnvironment More info https://t.co/YEBiwHL3Jb

[Marseille Immunopole @Immunopole]

#AACR19 “#InnateImmunity & complement in #SolidTumors” Chair @EricVivier1 @InnatePharma @aphm_actu @univamu @Immunopole @mellmani @genentech #RubénPío @CIMA_unav… packed room!

[Horowitz Lab @Icahn School of Medicine Mount Sinai @AmirHorowitz]

Beautiful talk by @MiriamMerad! @AACR describing phenotypic and functional diversity across DC subsets within the TME

[soria @jsoriamd]

The underlying biology of hyper progressive disease is unknown #AACR19

[Eric Vivier @EricVivier1]

Innate Pharma team this morning at AACR race against Cancer

[Science Immunology @SciImmunology]

ICYMI, @sloan_kettering scientists have identified new structures that play a critical role in one of the most protective kinds of #intercellular communication – the “lethal” interaction between a cytotoxic #Tcell and its targets: https://t.co/bSxUshQQha

[Horowitz Lab @Icahn School of Medicine Mount Sinai @AmirHorowitz]

Very proud of grad student, Dan Fu Ruan @df_ruan1 for stellar job in presenting effects of HLA-E expression as a major determinant of antitumor function at @KeystoneSymp . Thanks very much for the opportunity to present @Dr_Nick_Bikes @EricVivier1 #CarolineRobert an #LewisLanier!

[NatureRevClinOncol @NatRevClinOncol]

study provides mechanistic insight on the role of KRAS in colorectal cancer resistance to immune-checkpoint inh https://t.co/Q9ImztF918 #colorectalcancer

[Nicholas Huntington @Dr_Nick_Bikes]

Long lines of questions for the NK cell talks at @KeystoneSymp Lewis Lanier, Alberto Mantovani & myself we’re inundated by Q’s on how to drug the NK cell response to cancer. Amazing time to be a cancer immunology researcher

[Eric Vivier @EricVivier1]

Targeting Innate Immunity in Cancer
AACR 2019, Atlanta, March 31st
https://t.co/ARzZLWdQ0x
#AACR19

[Innate Pharma @InnatePharma]

Ce soir @InnatePharma est fière de recevoir le prix d’honneur 2019 des #Trophées de l'#Innovation d’@univamu avec @SATTse_ et @AMFrenchTech

[Marseille Immunopole @Immunopole]

#Trophées de l'#Innovation 2019 d’@univamu avec @SATTse_ @AMFrenchTech, @marseille @Immunopole à l’honneur : @InnatePharma reçoit le prix d’honneur tandis que @stephaniecornen remet le prix de la start-up santé à @ImcheckThx

[Innate Pharma @InnatePharma]

Come and meet us in San Francisco surrounding the JP Morgan conference @jpmorgan #JPM19 #JPM2019

[Innate Pharma @InnatePharma]

Innate Pharma celebrates its 20th Anniversary and wishes you a happy new year 2019 ! #HappyNewYear

[Marseille Immunopole @Immunopole]

A #cytostatic drug combination induces #cancer cell #senescence while also triggering #NKcell-dependent #AntitumorImmunity. #Ruscetti et al @sciencemag https://t.co/XxA7VBI5oM

[NatureRevClinOncol @NatRevClinOncol]

In an analysis of KEYNOTE-028, T-cell–inflamed gene-expression profile, PD-L1 expression, and TMB were found to predict efficacy of pembrolizumab across 20 cancer types: https://t.co/YDgg5q9BYM #ImmunoOnc

[Innate Pharma @InnatePharma]

Induction of #senescence: one way for #chemotherapy & #immunity to join forces against #cancer, #NKcells in the spotlight. Perspective @sciencemag on #Ruscetti et al paper by @EricVivier1 & @stephaniecornen @InnatePharma @univamu @aphm_actu @Immunopole https://t.co/TPYpjeH3AK